Preferred Name |
acrivastine |
|
Synonyms |
BW 825C |
|
ID |
http://purl.bioontology.org/ontology/MESH/C043648 |
|
altLabel |
BW 825C Semprex BW825C BW-825C 2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)- |
|
cui |
C0733885 C0592107 C0054340 |
|
Has mapping qualifier | ||
HM |
D014311/Q000031 |
|
Inverse of RB |
A20F9XAI7W |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19850103 |
|
MeSH Frequency |
71 |
|
MMR |
20161221 |
|
notation |
C043648 |
|
PA |
D039563 |
|
prefLabel |
acrivastine |
|
RR |
87848-99-5 |
|
SC |
1 |
|
Scope Statement |
a second generation antihistamine |
|
SRC |
Dermatologica 1984;169(4):179 |
|
TERMUI |
T158316 T621868 T158314 T158317 T158315 |
|
TH |
UK NL NLM (1985) INN (19XX) FDA SRS (2015) USAN (1985) |
|
tui |
T109 T121 |
Create mapping